Understanding the frequency and severity of side effects: Linguistic, numeric, and visual representations

AAAI Spring Symposium - Technical Report

Volumn SS-06-01, Issue , 2006, Pages 69-75

  Hubal, Rob ^a   Day, Ruth S ^b  

^a RTI INTERNATIONAL   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE LINGUISTIC; COMPLIANCE PROCESS; HEALTH LITERACY; SIDE EFFECTS;

DRUG PRODUCTS; HEALTH CARE; INFORMATION DISSEMINATION; LINGUISTICS; PATIENT MONITORING; PERSONNEL;

PHARMACOKINETICS;

EID: 33747198449     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (11)

1. Day, R.S. 1998. Optimizing Patient Comprehension through Medicine Leaflets: Cognitive Experiments. In Hartzema, A.G., Tolleson-Rinehart, S., Sleath, B.L., Day, R.S., and Bush, P.J. eds. Optimizing Patient Comprehension through Medicine Information Leaflets. Rockville, MD: United States Pharmacopeia Drug Quality and Information Program.
2. Day, R.S. 2006. Comprehension of Prescription Drug Information: An Empirical & Theoretical Research Program. In Proceedings of the AAAI Spring Symposium, Workshop on Argumentation for Consumers of Healthcare. Menlo Park, CA: AAAI Press.
3. Food and Drug Administration. 2006. Guidance for Industry: Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products Content and Format. Rockville, MD: U.S. Department of Health and Human Services.
4. Naranjo, C.A., Busto, U., Sellers, E.M., Sandor, P., Ruiz, I., Roberts, E.A., Janecek, E., Domecq, C., and Greenblatt, D.J. 1981. A Method for Estimating the Probability of Adverse Drug Reactions. Clinical Pharmacology and Therapeutics 30:239-245.
5. Calis, K.A. 2004. Clinical Analysis of Adverse Drug Reactions: A Primer for Clinicians. Hospital Pharmacy 39(7):697-712.
6. Chrvala, C.A., and Sharfstein, S. eds. 1999. Definition of Serious and Complex Medical Conditions. Washington, DC: Institute of Medicine (IOM).
7. Corso, D.M., Pucino, F., DeLeo, J.M., Calis, K.A., and Gallelli, J.F. 1992. Development of a Questionnaire for Detecting Potential Adverse Drug Reactions. The Annals of Pharmacotherapy 26(7-8):890-896.
8. Svensson, E. 2000. Comparison of the Quality of Assessments Using Continuous and Discrete Ordinal Rating Scales. Biometrical Journal 42:417-434.
9. Day, R.S. 1988. Alternative Representations. In Bower, G.H. ed. The Psychology of Learning and Motivation. New York: Academic Press, 22, 261-305.
10. Gurmankin, A.D., Baron, J., and Armstrong, K. 2004. The Effect of Numerical Statements of Risk on Trust and Comfort with Hypothetical Physician Risk Communication. Medical Decision Making 24(3):265-271.
11. Knapp, P., Raynor, D.K., and Berry, D.C. 2004. Comparison of Two Methods of Presenting Risk Information to Patients about the Side Effects of Medicines. Quality & Safety in Health Care 13:176-180.